Base to Base biotech podcast 35: Gothenburg Tech Week, osteoarthritis and respiratory virus infections
Asabys Partners integrates Aliath Bioventures Life Sciences investment platform
PDS Biotech seeking expedited approval pathway for head and neck cancer drug
Study identifies which patients benefit most from new schizophrenia drug
Base to Base biotech podcast 5: Vitalant’s vital role in blood products, and Brainomix gives hope to stroke victims
Base to Base biotech podcast 4: A new class of therapeutics, and biotech hiring in 2025
Base to Base biotech podcast 3: Nanoparticles and Duchenne muscular dystrophy
Canadian university researchers discover new class of antibiotics
Base to Base biotech podcast 2: Opioid alternatives and epiproteomics
Base to Base biotech podcast 1: Osteoboost and Pheast Therapeutics
SXSW announces 2025 pitch competition finalists
LinkGevity secures place in SPACE-H accelerator programme